3188 results for «639»

Filter By

3188 results

Opening - LIVE demonstration from National University Heart Centre Singapore

04 Jul 2019 – From AICT-AsiaPCR 2019

Complex distal left main bifurcation lesion

04 Jul 2019 – From AICT-AsiaPCR 2019

A 75-year-old male with multiple risk factors and a history of NSTEMI is admitted for staged PCI to his left main bifurcation. His vessels are diffusely calcified…

Complex distal left main bifurcation lesion

Calcified lesions

05 Jul 2019 – From AICT-AsiaPCR 2019

Watch this LIVE demonstration from National University Heart Centre (Singapore) to discover how they managed the case of a 69 years-old male with diabetes, hypertension and hyperlipidemia suffering from a calcified triple vessel disease.

Calcified lesions

Diffuse multivessel disease

05 Jul 2019 – From AICT-AsiaPCR 2019

Diffuse multivessel disease

AICT-AsiaPCR Opening Ceremony

04 Jul 2019 – From AICT-AsiaPCR 2019

Consult this session to watch AICT-AsiaPCR 2019 Opening Ceremony, led by Jean Fajadet. Discover the missions of PCR, and the novelties offered by the AICT-AsiaPCR course, arising from the Asia-Pacific region and showcasing its clinical research and innovations. 

AICT-AsiaPCR Opening Ceremony

TAVI in a bicuspid aortic valve stenosis

05 Jul 2019 – From AICT-AsiaPCR 2019

Watch this LIVE demonstration from Clinique Pasteur (France) to learn about the case of a 81 years-old male patient with dyslipidemia referred to the hospital because of NYHA II shortness of breath related to a severe aortic stenosis. CT scan revealed a type I L-R bicuspid...

TAVI in a bicuspid aortic valve stenosis

OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease

04 Nov 2021

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
OPTIMUM: Early Outcomes From a Prospective Registry of PCI in Patients at Prohibitive Risk for CABG

Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry

17 Sep 2022

Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry
Didn’t find what you were looking for?